Literature DB >> 29382606

Outcomes of infective endocarditis in the current era: Early predictors of a poor prognosis.

Maria Carmo Pereira Nunes1, Milton Henriques Guimarães-Júnior2, Pedro Henrique Oliveira Murta Pinto2, Rodrigo Matos Pinto Coelho3, Thais Lins Souza Barros2, Nicole de Paula Aarão Faleiro Maia2, Dayane Amaral Madureira2, Rodrigo Citton Padilha Reis4, Paulo Henrique Nogueira Costa2, Renato Bráulio2, Cláudio Léo Gelape2, Teresa Cristina Abreu Ferrari5.   

Abstract

BACKGROUND: The early identification of patients at risk of complications of infective endocarditis (IE) using parameters obtained as part of routine practice is essential for guiding clinical decision-making. This study aimed to identify a parameter at hospital admission that predicts the outcome, adding value to other well-known factors of a poor prognosis in IE.
METHODS: Two hundred and three patients with IE were included in this study. Clinical evaluation, echocardiography, blood cultures, and routine laboratory tests were performed at hospital admission. The endpoint was in-hospital mortality.
RESULTS: The mean age of the patients was 48.2±16.6 years; 62% were male and 38% had rheumatic heart disease. During treatment, cardiac surgery was performed in 111 patients (55%), and the overall in-hospital mortality rate was 32%. In the multivariable analysis, the independent predictors of death were age (odds ratio (OR) 1.07, 95% confidence interval (CI) 1.02-1.13), C-reactive protein (CRP) at hospital admission (OR 1.12, 95% CI 1.04-1.21), length of the vegetation at diagnosis (OR 1.15, 95% CI 1.03-1.28), development of heart failure (OR 6.43, 95% CI 2.14-19.33), and embolic events during antimicrobial therapy (OR 12.14, 95% CI 2.11-71.89).
CONCLUSIONS: An elevated CRP level at hospital admission and vegetation length at diagnosis were strong predictors of in-hospital mortality in IE, independent of other prognostic parameters, specifically taking into account patient characteristics and complications during therapy.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Echocardiography; Infective endocarditis; Mortality

Mesh:

Substances:

Year:  2018        PMID: 29382606     DOI: 10.1016/j.ijid.2018.01.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  9 in total

Review 1.  Infective endocarditis in paediatric population.

Authors:  Loay Eleyan; Ameer Ahmed Khan; Gledisa Musollari; Ashwini Suresh Chandiramani; Simran Shaikh; Ahmad Salha; Abdulla Tarmahomed; Amer Harky
Journal:  Eur J Pediatr       Date:  2021-04-14       Impact factor: 3.183

2.  Inflammatory biomarkers in infective endocarditis: machine learning to predict mortality.

Authors:  T Ris; A Teixeira-Carvalho; R Matos Pinto Coelho; C Brandao-de-Resende; M Souza Gomes; L Rodrigues Amaral; P H Oliveira Murta Pinto; L J Souza Santos; J Teixeira Salles; Jolien Roos-Hesselink; N Verkaik; T Cristina Abreu Ferrari; M C Pereira Nunes
Journal:  Clin Exp Immunol       Date:  2019-02-17       Impact factor: 4.330

3.  A changing profile of infective endocarditis at a tertiary hospital in China: a retrospective study from 2001 to 2018.

Authors:  Zuning Ren; Xichao Mo; Hongjie Chen; Jie Peng
Journal:  BMC Infect Dis       Date:  2019-11-08       Impact factor: 3.090

4.  In-hospital Outcomes of Infective Endocarditis from 1978 to 2015: Analysis Through Machine-Learning Techniques.

Authors:  Plinio Resende; Claudio Querido Fortes; Emilia Matos do Nascimento; Catarina Sousa; Natalia Rodrigues Querido Fortes; Diego Centenaro Thomaz; Basilio de Bragança Pereira; Fausto J Pinto; Glaucia Maria Moraes de Oliveira
Journal:  CJC Open       Date:  2021-09-11

5.  Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis.

Authors:  Rosa Zampino; Fabian Patauner; Arta Karruli; Domenico Iossa; Maria Paola Ursi; Lorenzo Bertolino; Anna Maria Peluso; Fabiana D'Amico; Giusi Cavezza; Emanuele Durante-Mangoni
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

6.  Infective Endocarditis in Diabetic Patients: A Different Profile with Prognostic Consequences.

Authors:  María Isabel Biezma; Patricia Muñoz; Sofía De la Villa; Mª Carmen Fariñas-Álvarez; Francisco Arnáiz de Las Revillas; Encarnación Gutierrez-Carretero; Arístides De Alarcón; Raquel Rodríguez-García; Jaume Llopis; Miguel Ángel Goenaga; Andrea Gutierrez-Villanueva; Antonio Plata; Laura Vidal; Manuel Martínez-Sellés
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.241

7.  Prognostic value of D-dimer for adverse outcomes in patients with infective endocarditis: an observational study.

Authors:  Ying-Wen Lin; Mei Jiang; Xue-Biao Wei; Jie-Leng Huang; Zedazhong Su; Yu Wang; Ji-Yan Chen; Dan-Qing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

8.  Clinical Status Quo of Infective Endocarditis in a University Hospital in Japan: A Single-hospital-based Retrospective Cohort Study.

Authors:  Shun Yamashita; Midori Tokushima; Tomotaro Nakashima; Naoko E Katsuki; Masaki Tago; Shu-Ichi Yamashita
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

9.  Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001-2015.

Authors:  José M de Miguel-Yanes; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Javier de Miguel-Díez; Manuel Méndez-Bailón; Nuria Muñoz-Rivas; Napoleón Pérez-Farinós; Ana López-de-Andrés
Journal:  Cardiovasc Diabetol       Date:  2019-11-21       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.